Fig. 1From: Subcutaneous glucagon infusion and continuous glucose monitoring enable effective management of hypoglycemia in a patient with IGF-2-producing hemangiopericytomaCGMS tracings from individual days, demonstrating (a) maintenance of euglycemia throughout the day. In the setting of pump dysfunction (b), overnight glucagon delivery ceased, precipitating hypoglycemiaBack to article page